All Posts By

Smartkarma Daily Briefs

Daily Brief Japan: Kioxia Holdings , Right On Co Ltd, Mitsui Mining & Smelting Co, Cybozu Inc, Kissei Pharmaceutical, LaKeel, Mamezo, Toyokoh, Caster and more

By | Daily Briefs, Japan

In today’s briefing:

  • The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge
  • Primer: Right On Co Ltd (7445 JP) – Nov 2025
  • Mitsui Kinzoku: Q2 FY2025 Upgrade Resets Earnings Baseline; Engineered Materials Accelerate
  • Primer: Cybozu Inc (4776 JP) – Nov 2025
  • Kissei Pharmaceutical (4547 JP): Guidance Upward Revision a Positive; Beova & Tavneos Still Key
  • LaKeel (4074 JP) – Guidance Unchanged, Visibility Needed
  • (19 Nov 2025) Mamezo(202A JP) — Fisco Company Research
  • (19 Nov 2025) Mamezo — Fisco Company Research
  • (20 Nov 2025) Toyoko <341A> — Fisco Company Research
  • (20 Nov 2025) Caster <9331> — Fisco Company Research


The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge

By Jay Cameron

  • Kioxia set for inclusion in the Nikkei Semiconductor Index next week, alongside JX Advanced Metals, less than one day’s average daily volume in passive inflow at the close.
  • Kioxia’s Q2 2025 results show an accelerating QoQ recovery and solid Q3 2025 forecasts, driven by high demand from data center and smart device products, confirming effective business structure reform.
  • Stock is fairly valued after 2025 rally, potential weaknesses being value metrics such as P/E alongside execution of margin and product pipeline targets.

Primer: Right On Co Ltd (7445 JP) – Nov 2025

By αSK

  • Right On Co. Ltd. is a jeans and casual wear retailer facing a prolonged period of declining revenues and significant financial losses, driven by intense competition and shifting consumer preferences in the Japanese apparel market.
  • Despite a challenging top-line trend, the company has shown some recent, albeit inconsistent, improvement in net income, suggesting that cost control measures may be taking effect. However, operating and free cash flows remain deeply negative, raising concerns about long-term sustainability.
  • The company’s strategy is centered on its core competency in denim, leveraging both national and private brands, and optimizing its nationwide network of stores, which are primarily located in shopping centers. A pivot towards enhancing e-commerce and adapting product assortments to local tastes is critical for a potential turnaround.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Mitsui Kinzoku: Q2 FY2025 Upgrade Resets Earnings Baseline; Engineered Materials Accelerate

By Rahul Jain

  • FY2025 operating profit sharply upgraded; earnings base rebased higher across FY2026–28.
  • Engineered Materials accelerating with VSP™ and FaradFlex® capacity expansions; ~25–30% OP CAGR implied.
  • Metals more resilient than expected; ¥50 bn buyback supports valuation despite recent re-rating.

Primer: Cybozu Inc (4776 JP) – Nov 2025

By αSK

  • Cybozu is a dominant player in the Japanese groupware market, capitalizing on the nationwide push for digital transformation (DX). Its flagship no-code/low-code platform, Kintone, is a key growth driver, empowering businesses to create custom applications and streamline workflows.
  • The company exhibits a strong financial track record, characterized by consistent double-digit revenue growth and improving profitability. The shift to a cloud-first, SaaS-based model has resulted in high gross margins and recurring revenue streams.
  • Strategic focus is on expanding Kintone’s adoption within large enterprises and accelerating international growth, particularly in Southeast Asia. Investments in a partner ecosystem and new technologies like generative AI are expected to support long-term expansion, though they may impact short-term margins.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Kissei Pharmaceutical (4547 JP): Guidance Upward Revision a Positive; Beova & Tavneos Still Key

By Tina Banerjee

  • Kissei Pharmaceutical (4547 JP) reported 7.9% YoY jump in revenue during H1FY26 driven by Beova, Tavneos and IT services amidst price revision pressures and generic competition.
  • Kissei beat their H1FY26 guidance numbers. This compelled the company to revise their FY26 guidance numbers upwards.
  • An NDA application was submitted in Japan in February 2025 for Linzagolix. The next big trigger would be Linzagolix receiving the approval for treatment of uterine fibroids in Japan.  

LaKeel (4074 JP) – Guidance Unchanged, Visibility Needed

By Astris Advisory Japan

  • Following on from a strong set of earnings in the previous quarter and an upward revision to FY guidance, Q1-3 FY12/25 results were a negative surprise, with both sales and OP being flat to down YoY.
  • Results were impacted by Licence opportunities not closing as planned, and Consulting and Professional Services experiencing slower activity levels.
  • Atypical for the company, Q3 FY12/25 OPM was negative, partly due to one-time event costs. 

(19 Nov 2025) Mamezo(202A JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • FISCO Ltd. anticipates a positive outlook due to strategic investments in AI robotics, with limited tariff risk impact.
  • The projected price-to-earnings ratio (PER) is between 30 to 60 times, indicating strong growth expectations.
  • The company revised its dividend forecast to 30.00 yen interim and 31.00 yen full-year, with a target payout ratio of 50% to 70%.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


(19 Nov 2025) Mamezo — Fisco Company Research

By FISCO

Key points (machine generated)

  • FISCO Ltd.’s report indicates diminishing tariff risks and growth potential from AI robotics investments.
  • The company has a price-earnings ratio forecast of 30 to 60 times and revised its interim dividend to 30.00 yen per share.
  • Despite stock price increases, the dividend yield is approximately 2%, with a target payout ratio of 50% to 70%.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


(20 Nov 2025) Toyoko <341A> — Fisco Company Research

By FISCO

Key points (machine generated)

  • FISCO Ltd.’s report highlights Toyoko’s transition of the CoolLaser business from R&D to monetization, projecting over 50% CAGR with 120 units sold.
  • The stock price has risen post-listing, indicating investor confidence in Toyoko’s profit growth and favorable PER evaluation similar to AI sectors.
  • The report anticipates record profits for the fiscal year ending March 2026, driven by increasing demand from aging infrastructure globally.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


(20 Nov 2025) Caster <9331> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Caster, listed on the Tokyo Stock Exchange Growth Market in October 2023, reported increased revenue but an operating loss for the fiscal year ending August 2025.
  • The company focuses on alleviating labor shortages for SMEs by connecting them with remote workers, promoting remote work normalization.
  • Caster has over 5,800 users, primarily from startups and SMEs, employs around 800 individuals, and operates entirely remotely.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Contemporary Amperex Technology (CATL), Tata Capital Limited, DeNA, SBI Shinsei Bank, 3SBio Inc, Kioxia Holdings , LG Corp, UltraGreen.ai, Alliance Laundry Holdings and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Dec25
  • AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings
  • [Japan Pump ‘n Dump] Murakami Group Starts Selling The Day After Reporting 5%
  • SBI Shinsei Bank (8303 JP) IPO: Valuation Insights
  • 3SBio (1530 HK)’s Spin-Off and Listing of Mandi Inc.
  • The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge
  • HEW: Micro Risk Off
  • Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle
  • UltraGreen.ai Pre-IPO: Strong Financials Despite Misleading Branding
  • US: 19 IPOs Forecasted for Index Addition in December 2025


Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Dec25

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 5 December.
  • We highlight 6 stocks that have a higher probability of being added to the index. With the index committee entitled to a lot of discretion, there will be differences.
  • CATL (3750 HK) will have a 6-month trading history by implementation of the index changes and is a high probability inclusion to the index. But cornerstone lock-up ends tomorrow.

AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings

By Brian Freitas

  • We forecast 7 stocks moving from MidCap to LargeCap, 10 stocks moving from LargeCap to MidCap, 3 stocks from SmallCap to MidCap, and 11 stocks from MidCap to SmallCap.
  • From the new listings, 13 stocks are expected to be added to Large Cap, 5 stocks are expected to be added to Mid Cap, and multiple stocks to Small Cap.
  • With the review period nearing completion, there could still be more outperformance given the momentum, but we would look to take profit on the stocks as the divergence gets wider.

[Japan Pump ‘n Dump] Murakami Group Starts Selling The Day After Reporting 5%

By Travis Lundy

  • On 20 October, Murakami Group reported they’d gone over 5% in cash/asset-rich DeNA (2432 JP). Not easy with insiders+Crossholders at 39%, passive at 24%. But not impossible. 
  • On 30 October, they reported they’d gone to 6.31% on 23 October (four days before they reported the 5%. 
  • As reported here before, Murakami-san sometimes does what might charitably be called a headfake, less charitably a Pump ‘n Dump. 

SBI Shinsei Bank (8303 JP) IPO: Valuation Insights

By Arun George


3SBio (1530 HK)’s Spin-Off and Listing of Mandi Inc.

By David Blennerhassett

  • Pharma-Play 3SBio Inc (1530 HK) has announced the spin-off and listing of 87.16%-held Mandi (MANDI HK)  on the HKEx. 
  • 3SBio will distribute its stake in-specie. There will be a concurrent global offering, the details of which are still to be fleshed out. 
  • Mandi (MANDI HK), a ” hair loss and weight management treatments” solutions provider, accounted for 17% of 3SBio’s revs in the 1H25, and 12.5% of profit.

The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge

By Jay Cameron

  • Kioxia set for inclusion in the Nikkei Semiconductor Index next week, alongside JX Advanced Metals, less than one day’s average daily volume in passive inflow at the close.
  • Kioxia’s Q2 2025 results show an accelerating QoQ recovery and solid Q3 2025 forecasts, driven by high demand from data center and smart device products, confirming effective business structure reform.
  • Stock is fairly valued after 2025 rally, potential weaknesses being value metrics such as P/E alongside execution of margin and product pipeline targets.

HEW: Micro Risk Off

By Phil Rush

  • Risk assets have suffered, despite decent Nvidia results suggesting AI demand hasn’t turned yet, and the macro data remaining resilient. Fears are more theme-specific.
  • US labour market activity entered the shutdown solidly, and low jobless claims suggest it survived fine. Meanwhile, UK inflation only lost a little excess, and our forecast rose.
  • Next week’s UK Budget is the lowlight of our week, but it may struggle to live up to all the noisy hype. Sneaky backloaded tax hikes will close the latest forecast hole again.

Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle

By Sanghyun Park

  • Starting next week, the tax subcommittee is set to hash out the 25% proposal, and with the opposition unlikely to block it, the 25% top rate is basically locked in.
  • The street’s treating 30% payout as base case, betting on more upside. The committee may pick it up next week, with headlines likely hitting the KRX tape fast.
  • Locals are already chasing 30%+ payout, deep-value names, with gov’t aiming for a Taiwan-style re-rating. If dividend-tax headlines drop next week, these screened names could rip.

UltraGreen.ai Pre-IPO: Strong Financials Despite Misleading Branding

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) is looking to raise US$400m in its upcoming Singapore IPO.
  • Ultragreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • In this note, we look at the company’s past performance.

US: 19 IPOs Forecasted for Index Addition in December 2025

By Dimitris Ioannidis


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Utilities: Brookfield Infrastructure Partners L.P., Eversource Energy, Fortis /Canada and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Primer: Brookfield Infrastructure Partners L.P. (BIP US) – Nov 2025
  • Eversource Energy: How Will Its Electrification Push Spark a Massive Growth Wave?
  • Fortis Inc.: Infrastructure Expansion Uncertainty & Other Critical Challenges In Its Path!


Primer: Brookfield Infrastructure Partners L.P. (BIP US) – Nov 2025

By αSK

  • Diversified Pure-Play Infrastructure Leader: Brookfield Infrastructure Partners (BIP) is one of the largest publicly traded, globally diversified owners and operators of critical infrastructure networks across utilities, transport, midstream, and data sectors. This diversification provides resilience and exposure to various macroeconomic tailwinds.
  • Proven Value Creation Model: BIP employs a disciplined, value-oriented investment strategy focused on acquiring high-quality assets, enhancing their performance through operational expertise, and opportunistically recycling capital from mature assets into higher-growth opportunities. The company targets a 12-15% total return on its investments.
  • Commitment to Shareholder Returns: The partnership has a strong track record of delivering long-term growth in Funds From Operations (FFO) per unit and aims for annual distribution growth of 5-9%. This focus on sustainable and growing distributions is a cornerstone of its value proposition for institutional investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Eversource Energy: How Will Its Electrification Push Spark a Massive Growth Wave?

By Baptista Research

  • Eversource Energy reported its third-quarter 2025 financial results, evidencing both strategic progress and challenges.
  • The company’s GAAP earnings for the quarter were $0.99 per share, factoring in a significant nonrecurring charge of $75 million related to its offshore wind liability, offset by tax benefits.
  • Excluding this charge, non-GAAP earnings were $1.19 per share, up from $1.13 the prior year, mostly driven by infrastructure investments and strategic rate increases across various segments, including natural gas and electric distribution.

Fortis Inc.: Infrastructure Expansion Uncertainty & Other Critical Challenges In Its Path!

By Baptista Research

  • Fortis Inc.’s third-quarter 2025 earnings call highlights a structured approach towards achieving regulated growth, complemented by strategic asset sales to refine their investment profile.
  • The recent divestiture of Fortis Turks and Caicos (FortisTCI) and investments in Belize underscore a transition to 100% regulated assets, which aims at streamlining the company’s operational framework towards reducing risk and volatility.
  • Operational efficiency remains a core tenet of Fortis’s strategy.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: LG Corp, Caster , Equifax Inc, Kelington Group, Uber Technologies and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle
  • (20 Nov 2025) Caster <9331> — Fisco Company Research
  • Equifax’s Vault Verify Acquisition: Can It Supercharge TWN & Government Growth?
  • Primer: Kelington Group (KGRB MK) – Nov 2025
  • Uber Technologies Pushes a Powerful Growth Flywheel Driven by AI


Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle

By Sanghyun Park

  • Starting next week, the tax subcommittee is set to hash out the 25% proposal, and with the opposition unlikely to block it, the 25% top rate is basically locked in.
  • The street’s treating 30% payout as base case, betting on more upside. The committee may pick it up next week, with headlines likely hitting the KRX tape fast.
  • Locals are already chasing 30%+ payout, deep-value names, with gov’t aiming for a Taiwan-style re-rating. If dividend-tax headlines drop next week, these screened names could rip.

(20 Nov 2025) Caster <9331> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Caster, listed on the Tokyo Stock Exchange Growth Market in October 2023, reported increased revenue but an operating loss for the fiscal year ending August 2025.
  • The company focuses on alleviating labor shortages for SMEs by connecting them with remote workers, promoting remote work normalization.
  • Caster has over 5,800 users, primarily from startups and SMEs, employs around 800 individuals, and operates entirely remotely.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Equifax’s Vault Verify Acquisition: Can It Supercharge TWN & Government Growth?

By Baptista Research

  • Equifax Inc.’s results for the third quarter of 2025 reflect a period of robust revenue growth intertwined with complex operational adjustments.
  • The company reported a revenue of $1.54 billion, marking a growth of over 7% in both constant currency and reported dollars.
  • This performance surpassed the guidance provided in July by $25 million, primarily courtesy of strong performance in U.S. mortgage, Employment & Income Verification (EWS), and U.S. Information Solutions (USIS) non-mortgage sectors.

Primer: Kelington Group (KGRB MK) – Nov 2025

By αSK

  • Integrated Engineering and Industrial Gas Provider with Strong Regional Presence: Kelington Group Berhad (KGB) is a Malaysia-based investment holding company that provides integrated engineering services, construction, and general trading. The company operates through two main segments: Engineering and Industrial Gases, serving a diverse range of industries including electronics, semiconductor, petrochemical, and food and beverage across Malaysia, Singapore, China, and Taiwan.
  • Leveraging Growth in the Semiconductor Industry: A significant portion of KGB’s business is tied to the semiconductor sector through its Ultra-High Purity (UHP) division, which provides gas and chemical delivery solutions. The company is well-positioned to benefit from the long-term growth of the semiconductor industry, driven by advancements in AI, IoT, and electric vehicles. Recent expansion into Germany and Hong Kong is a strategic move to capture a larger share of the global semiconductor capital expenditure.
  • Diversified Business Model Mitigates Cyclicality: While the UHP segment is a primary revenue contributor, KGB has diversified its operations to include Process Engineering, General Contracting, and an Industrial Gases division. This diversification helps to mitigate the risks associated with the cyclical nature of the semiconductor industry and provides multiple avenues for growth. The industrial gases business, particularly the supply of liquid carbon dioxide (LCO2), is a key pillar for future growth with strong demand from the food and beverage sector.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Uber Technologies Pushes a Powerful Growth Flywheel Driven by AI

By Baptista Research

  • Uber Technologies, Inc. recently reported its third-quarter 2025 earnings, highlighting solid growth in its operations, both in Mobility and Delivery sectors.
  • The company recorded a marked increase in trips by 22%, the fastest growth since 2023, driven predominantly by enhancements in innovation and execution strategies.
  • As a result of strong audience engagement and operational efficiency, gross bookings grew by 21% while maintaining relatively stable pricing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Mitsui Mining & Smelting Co, Rio Tinto , Future Metals NL, Kinross Gold Corp, Martin Marietta Materials, Ovintiv , Pan American Silver, Sailfish Royalty , Axalta Coating Systems, SolarBank and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Mitsui Kinzoku: Q2 FY2025 Upgrade Resets Earnings Baseline; Engineered Materials Accelerate
  • As Simandou Opens the Floodgates, Rio Tinto Finds a New Edge in the Premium Ore Race
  • Primer: Future Metals NL (FME AU) – Nov 2025
  • Kinross Gold: Sensitivity to Gold Price Movements Given Mid-Cost Curve Positioning & 4 Critical Challenges!
  • Martin Marietta Is Betting Big on Rail—Could This Power Move Transform Its Future?
  • Ovintiv Makes a Bold Move With NuVista — How Will This Mega-Acquisition Redefine Free Cash Flow Power?
  • Pan American Silver — First contribution from Juanicipio
  • FISH: Q3 Financials; Everything Going to Plan
  • Axalta Coating Systems Ltd – What’s News in Amsterdam
  • SUUN: First quarter results exceed expectations. Strong backlog counters headwinds in the Solar and BESS markets.


Mitsui Kinzoku: Q2 FY2025 Upgrade Resets Earnings Baseline; Engineered Materials Accelerate

By Rahul Jain

  • FY2025 operating profit sharply upgraded; earnings base rebased higher across FY2026–28.
  • Engineered Materials accelerating with VSP™ and FaradFlex® capacity expansions; ~25–30% OP CAGR implied.
  • Metals more resilient than expected; ¥50 bn buyback supports valuation despite recent re-rating.

As Simandou Opens the Floodgates, Rio Tinto Finds a New Edge in the Premium Ore Race

By Umang Agrawal

  • Simandou’s planned 120 Mt annual output could supply about 6% of global seaborne ore by 2030, pressuring Australia and Brazil and shifting premium-grade pricing.
  • Despite Guinea’s push to diversify buyers, roughly three-quarters of Simandou’s ownership ties back to China, making most tonnage effectively committed to Chinese mills.
  • Weak Chinese steel margins and a 12% YoY drop in October output limit near-term uptake, but long-term decarbonisation trends support stronger demand for high-grade feedstock.

Primer: Future Metals NL (FME AU) – Nov 2025

By αSK

  • Future Metals NL is an exploration-stage company focused on its 100% owned Panton PGM-Nickel Project in Western Australia, which is considered the highest-grade PGM deposit in Australia.
  • The Panton project has a significant JORC Mineral Resource Estimate of 4.5 million ounces of PGM and 185,000 tonnes of nickel, positioning it as a globally significant PGM resource outside of the primary supply jurisdictions of Russia and South Africa.
  • While the project shows robust economics in a December 2023 Scoping Study, the company is currently pre-revenue and faces the typical risks of an exploration company, including financing, development, and commodity price risks.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Kinross Gold: Sensitivity to Gold Price Movements Given Mid-Cost Curve Positioning & 4 Critical Challenges!

By Baptista Research

  • Kinross Gold Corporation’s latest financial performance shows a blend of optimism and caution for investors.
  • The company reported a strong third quarter, indicating an efficient operational execution across its global mining assets.
  • Production was in line with expectations at approximately 504,000 ounces at a cost of sales of $1,145 per ounce.

Martin Marietta Is Betting Big on Rail—Could This Power Move Transform Its Future?

By Baptista Research

  • Martin Marietta Materials reported an impressive third quarter for 2025, marked by record performance across both aggregates and specialties, emphasizing the enduring strength of its business model and strategic focus.
  • Aggregates revenues increased by 17% ($1.5 billion), with gross margins improving to 36%.
  • The Specialties business also set records, achieving a 60% revenue increase to $131 million.

Ovintiv Makes a Bold Move With NuVista — How Will This Mega-Acquisition Redefine Free Cash Flow Power?

By Baptista Research

  • Ovintiv’s recent quarterly earnings call provides a robust overview of the company’s strategic initiatives, financial performance, and future outlook as it continues to solidify its position as a leading North American independent oil and gas exploration and production company.
  • From the information available, several key themes emerge, showcasing both strengths and areas requiring caution.
  • Firstly, Ovintiv’s acquisition of NuVista Energy presents a significant strategic move.

Pan American Silver — First contribution from Juanicipio

By Edison Investment Research

Pan American Silver’s Q325 results saw the initial 27-day contribution from the recently acquired 44% interest in the Juanicipio project, which boosted its attributable silver production by c 10% and lowered the silver segment all-in sustaining cost (AISC) to an impressive US$15.4/oz. EBITDA adjusted for equity investment in the project was up 51% y-o-y and 11% q-o-q. We have upgraded our estimates on higher commodity prices and Juanicipio, raising our discounted cash flow (DCF)-based valuation of PAAS from US$38.0/share to US$43.5/share. The company is also evaluating a two-stage development approach for Skarn to maximise the value of the combined deposit, which, in our view, is not yet full priced in by the market.


FISH: Q3 Financials; Everything Going to Plan

By Atrium Research

  • Sailfish Royalty reported Q3 financial results, including revenue of $0.9M (vs. our estimate of $0.7M) and adjusted EBITDA of $0.4M (vs. our estimate of $0.2M).
  • Spring Valley continues to progress with Wheaton Precious Metals entering into a $670M stream on the project.
  • This places a premium valuation onto FISH’s Spring Valley royalties compared to our model.

Axalta Coating Systems Ltd – What’s News in Amsterdam

By The IDEA!

  • In today’s edition: • ABN Amro | announced further reduction of its flexible workforce • AkzoNobel | Cevian pledges support for AkzoNobel/Axalta merger • InPost | enters cross-border deal with Austrian Post for business customers • Unilever | said to be exploring the sale of three UK heritage brands • Corbion | targets adjusted EBITDA of approx. EUR 300m by 2028 • bpostgroup | renews contract with Amazon for 5 years

SUUN: First quarter results exceed expectations. Strong backlog counters headwinds in the Solar and BESS markets.

By Zacks Small Cap Research

  • PowerBank reported first-quarter results that exceeded our expectations on the top and bottom line.
  • Quarterly revenues will remain uneven as the company transitions to become an independent power producer over the coming years.
  • Near-term demand should remain strong in the US solar market ahead of the expiration of the solar investment tax credit, but the outlook is less certain beyond 2026.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Kioxia Holdings , Intel Corp, Astera Labs , Advanced Micro Devices, Adobe Systems, Palo Alto Networks, Leidos Holdings, Nebius Group, Klook, Tyler Technologies and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge
  • How 172% DRAM Spikes Turn Intel’s ‘Worst’ Feature Into Its Best Asset
  • Astera Labs: What Scorpio X Reveals About Its Bold Diversification Strategy!
  • Advanced Micro Devices (AMD): Expansion Of Its Space-Grade Adaptive SoC Portfolio Could Supercharge Growth!
  • Adobe’s $1.9 Billion Semrush Buy: Brilliant Strategy or Costly Distraction?
  • Palo Alto Is Quietly Building a Cloud Empire—The Chronosphere Acquisition Is Just the Start!
  • Leidos Accelerates a Defense Supercycle Fueled by Hypersonics & Radar Innovation!
  • Nvidia Earnings Read-Across; Now for Something (Very) Different!
  • Klook IPO (NYSE: KLK): Fair Valuation Would Be Significantly Above Last Reported Valuation
  • Tyler Technologies Snaps Up CloudGavel—What’s The Real Play Here?


The Nikkei Semiconductor Index Rebalance, Kioxia, Nikkei Volatility Hedge

By Jay Cameron

  • Kioxia set for inclusion in the Nikkei Semiconductor Index next week, alongside JX Advanced Metals, less than one day’s average daily volume in passive inflow at the close.
  • Kioxia’s Q2 2025 results show an accelerating QoQ recovery and solid Q3 2025 forecasts, driven by high demand from data center and smart device products, confirming effective business structure reform.
  • Stock is fairly valued after 2025 rally, potential weaknesses being value metrics such as P/E alongside execution of margin and product pipeline targets.

How 172% DRAM Spikes Turn Intel’s ‘Worst’ Feature Into Its Best Asset

By Raghav Vashisht

  • DRAM has jumped 172 % YoY and is still climbing; another 30–50 % hike is baked into Q4, wiping out the 4–6 % operating margins most PC OEMs live on.
  • Intel’s soldered-down LPDDR5X, once hated for killing the lucrative RAM-up-sell, now locks the memory cost inside the processor.
  • With memory inflation off their books via a safe margin play, OEMs can hold notebook ASPs and guidance

Astera Labs: What Scorpio X Reveals About Its Bold Diversification Strategy!

By Baptista Research

  • Astera Labs delivered strong third-quarter results for fiscal year 2025, surpassing their expectations with a notable increase in revenue and profitability metrics.
  • The company’s quarterly revenue reached $230.6 million, marking a 20% increase from the previous quarter and a remarkable 104% growth compared to the same period last year.
  • This significant growth was driven by broad-based performance across its product lines, including signal conditioning, smart cable modules, and switch fabrics.

Advanced Micro Devices (AMD): Expansion Of Its Space-Grade Adaptive SoC Portfolio Could Supercharge Growth!

By Baptista Research

  • Advanced Micro Devices (AMD) reported a robust third quarter in 2025, showcasing significant revenue growth across its business segments driven by strong product demand.
  • For the quarter, AMD’s revenue increased by 36% year-over-year, reaching $9.2 billion.
  • This growth was broad-based, with strong performance in the data center, server, gaming, and PC segments.

Adobe’s $1.9 Billion Semrush Buy: Brilliant Strategy or Costly Distraction?

By Baptista Research

  • Adobe Systems Incorporated has reported strong financial results for the third quarter of fiscal year 2025, showcasing continued double-digit growth in both revenue and profitability, driven largely by its strategic emphasis on artificial intelligence (AI).
  • The company saw record revenue of $5.99 billion, marking a 10% increase year-over-year, while GAAP earnings per share reached $4.18 and non-GAAP earnings per share was $5.31, reflecting an impressive 14% growth.
  • The incorporation of AI into Adobe’s product suite has been a significant focus, as exemplified by the deployment of AI innovations across its flagship Creative Cloud applications like Photoshop, Illustrator, and Premiere Pro.

Palo Alto Is Quietly Building a Cloud Empire—The Chronosphere Acquisition Is Just the Start!

By Baptista Research

  • Palo Alto Networks recently discussed their fourth quarter financial results, detailing both positive achievements and certain challenges.
  • The company reported a significant growth trajectory, crossing the $10 billion revenue mark, a first for a dedicated cybersecurity company.
  • This milestone reflects the successful execution of a long-term strategy focused on preemptive cybersecurity advancements tailored to match the evolving market landscape.

Leidos Accelerates a Defense Supercycle Fueled by Hypersonics & Radar Innovation!

By Baptista Research

  • Leidos Holdings, Inc., a prominent player in the defense, aviation, information technology, and biomedical research fields, has reported a solid financial performance for the third quarter of 2025.
  • The company continues to display resilience in navigating a dynamic and uncertain macroeconomic landscape, bolstered by its strategic initiatives and governmental partnerships.
  • Leidos reported a 7% year-over-year increase in revenue to $4.47 billion, illustrating strong top-line growth despite challenges such as the government shutdown and previous headwinds from efficiency reviews.

Nvidia Earnings Read-Across; Now for Something (Very) Different!

By Water Tower Research

  • Strong Nvidia beat reinforces strength in demand environment for AI. 
  • Nvidia’s 3QFY26 results materially exceeded consensus expectations, with revenue of $57.0 billion (+22% Q/Q, +62% Y/Y) versus Street estimates of ~$54.9 billion and adjusted EPS of $1.30 versus Street estimates of $1.25.
  • Data center revenue of $51.2 billion handily surpassed consensus of ~$49.0 billion, accounting for 90% of total revenue and underscoring sustained enterprise AI adoption.

Klook IPO (NYSE: KLK): Fair Valuation Would Be Significantly Above Last Reported Valuation

By Andrei Zakharov

  • Klook Technology Limited, travel and leisure booking platform company with leadership position in APAC intra-regional travel, aims to raise up to $500M in US IPO.
  • The company is expected to IPO in December. Goldman Sachs, J.P. Morgan and Morgan Stanley are leading the offering and Klook will list its ADSs on the NYSE.
  • My IPO valuation analysis coalesces around initial valuation range between $2.5B and $3.5B for Klook Technology Limited upcoming offering.

Tyler Technologies Snaps Up CloudGavel—What’s The Real Play Here?

By Baptista Research

  • Tyler Technologies reported strong third-quarter 2025 results, with revenues growing by nearly 10% year-over-year.
  • This growth was driven by a 20% increase in SaaS revenue and an 11.5% rise in transaction revenue.
  • The company has maintained a steady pipeline of business, supported by stable RFP and demo activities, suggesting a resilient demand in the public sector for Tyler’s solutions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Live Nation Entertainment, Inc, Health And Happiness (H&H), Right On Co Ltd, Yum! Brands Inc, Kontoor Brands , Green Cross Health, Games Workshop Group PLC, Rivian Automotive , SJM Holdings, Toyokoh and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Live Nation Is Quietly Building a Global Entertainment Empire—And No One’s Ready!
  • Health & Happiness: On Deleveraging Path
  • Primer: Right On Co Ltd (7445 JP) – Nov 2025
  • Yum! Brands: An Insight Into Its Franchisee & Store-Level Economic Strength & Key Growth Levers!
  • Kontoor’s Global Diversification Bet: Will the Helly Hansen Partnership Become Its Most Valuable Growth Engine Yet?
  • Primer: Green Cross Health (GXH NZ) – Nov 2025
  • Games Workshop Group — Core strength supports profit upgrade
  • Rivian’s R2 Strategy Looks Bold—Can Domestic Sourcing Become Its Ultimate Competitive Weapon?
  • Lucror Analytics – Morning Views Asia
  • (20 Nov 2025) Toyokoh(341A JP) — Fisco Company Research


Live Nation Is Quietly Building a Global Entertainment Empire—And No One’s Ready!

By Baptista Research

  • Live Nation Entertainment recently discussed its performance and strategy during its investor meeting, highlighting both opportunities and challenges facing the company.
  • Live Nation, a dominant player in the live entertainment industry, has projected continuous growth in its key markets, leveraging global expansion and consumer trends.
  • One of the significant highlights is the company’s outlook on the industry.

Health & Happiness: On Deleveraging Path

By Warut Promboon

  • We initiate our coverage on Health and Happiness International Holding Limited (H&H)’s BTSDF 9.125% 24Jul2028.
  • H&H has refinanced USD320m of 2026 notes with the new USD300m of 2028 notes at a 9.125% coupon. The new bonds help extend its debt maturity and lower financing cost.
  • The bonds offer diversification and a chance to invest back in China after the fallout in the property sector. We assign an OVERWEIGHT recommendation.

Primer: Right On Co Ltd (7445 JP) – Nov 2025

By αSK

  • Right On Co. Ltd. is a jeans and casual wear retailer facing a prolonged period of declining revenues and significant financial losses, driven by intense competition and shifting consumer preferences in the Japanese apparel market.
  • Despite a challenging top-line trend, the company has shown some recent, albeit inconsistent, improvement in net income, suggesting that cost control measures may be taking effect. However, operating and free cash flows remain deeply negative, raising concerns about long-term sustainability.
  • The company’s strategy is centered on its core competency in denim, leveraging both national and private brands, and optimizing its nationwide network of stores, which are primarily located in shopping centers. A pivot towards enhancing e-commerce and adapting product assortments to local tastes is critical for a potential turnaround.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Yum! Brands: An Insight Into Its Franchisee & Store-Level Economic Strength & Key Growth Levers!

By Baptista Research

  • Yum!
  • Brands, Inc. delivered a robust performance in the third quarter of 2025, accentuated by strong system sales and core operating profit growth.
  • The company’s comprehensive strategy focused on leveraging its scale and brand strengths, primarily through its key brands, KFC and Taco Bell, which collectively account for a significant portion of its operating profit.

Kontoor’s Global Diversification Bet: Will the Helly Hansen Partnership Become Its Most Valuable Growth Engine Yet?

By Baptista Research

  • Kontoor Brands has demonstrated a strong performance in the third quarter of 2025, highlighted by growth in its core brands and a strategic expansion in its portfolio.
  • The quarter’s results reflect successful integration and growth initiatives that offer both immediate benefits and promising long-term prospects.
  • Helly Hansen, a recent acquisition by Kontoor Brands, showed significant growth, with revenues increasing by 11%.

Primer: Green Cross Health (GXH NZ) – Nov 2025

By αSK

  • Green Cross Health is a leading integrated primary healthcare provider in New Zealand, operating a large network of pharmacies under the Unichem and Life Pharmacy brands, and medical centers primarily under ‘The Doctors’ brand.
  • The company faces a challenging operating environment characterized by insufficient government funding, inflationary pressures, and constrained consumer spending, which has impacted profitability despite revenue growth.
  • Future strategy is centered on organic growth through the expansion of pharmacy services, strengthening its retail beauty and wellness offerings, investing in technology, and advocating for regulatory changes to broaden the scope of pharmacist services and simplify medical center funding.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Games Workshop Group — Core strength supports profit upgrade

By Edison Investment Research

Games Workshop Group’s (GAW’s) H126 trading update shows a strong performance by the core business with an accompanying improvement in operating margin. This is impressive given the comparatives from the two prior years when the most recent editions of its major intellectual properties were released. This also suggests good ongoing sales of new products from each of these properties, as well as other new products this year. We increase our FY26e profit by c 12% and raise our forecast dividend to £5.20 per share to be consistent with FY25 levels, despite our lower forecast profit.


Rivian’s R2 Strategy Looks Bold—Can Domestic Sourcing Become Its Ultimate Competitive Weapon?

By Baptista Research

  • Rivian Automotive’s third-quarter 2025 financial results reflect mixed performance and strategic advancements, which provide multiple dimensions for assessment for potential investors.
  • The U.S.-based electric vehicle (EV) manufacturer continues to focus on expanding its product offerings, enhancing its technological capabilities, and scaling its manufacturing capacity.
  • While there are positives in Rivian’s broader strategy, the financial results reveal challenges that the company faces in terms of profitability and cost management.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • UST yields fell meaningfully yesterday, with the curve bull steepening as market expectations for Fed rate cuts climbed.
  • This followed an uptick in the September unemployment rate, despite payrolls data coming in above estimates.
  • The yield on the 2Y UST decreased 6 bps to 3.53%, while that on the 10Y UST declined 5 bps to 4.09%. 

(20 Nov 2025) Toyokoh(341A JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • Toyoko has recently been listed on the Tokyo Stock Exchange Growth, focusing on its CoolLaser business.
  • The company’s Medium-Term Management Plan anticipates selling 120 units with a CAGR of over 50% in operating profit.
  • The report highlights strong demand for CoolLaser products and record profit expectations for the fiscal year ending March 2026.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: 3SBio Inc, UltraGreen.ai, Apellis Pharmaceuticals, Bristol Myers Squibb Co, Chordia Therapeutics, Cooper Cos, Genmab A/S, Halozyme Therapeutics, Jazz Pharmaceuticals and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • 3SBio (1530 HK)’s Spin-Off and Listing of Mandi Inc.
  • UltraGreen.ai Pre-IPO: Strong Financials Despite Misleading Branding
  • Primer: Apellis Pharmaceuticals (APLS US) – Nov 2025
  • Bristol Myers Crashes Again: Another Trial Failure Shocks Investors
  • (20 Nov 2025) Chordia Therapeutics<190A> — Fisco Company Research
  • (20 Nov 2025) Chordia Therapeutics(190A JP) — Fisco Company Research
  • Cooper Companies at a Crossroads: Activists Want In, Will the Board Give In?
  • Genmab’s $8 Billion Bet: What The Merus Deal Could Unlock!
  • Halozyme’s Breakthrough Moment: Could Its Game-Changing Subcutaneous Tech Disrupt Cancer Care Forever?
  • Jazz Pharmaceuticals’ Ziihera Trial Rocks the Market—A New Era in Oncology?


3SBio (1530 HK)’s Spin-Off and Listing of Mandi Inc.

By David Blennerhassett

  • Pharma-Play 3SBio Inc (1530 HK) has announced the spin-off and listing of 87.16%-held Mandi (MANDI HK)  on the HKEx. 
  • 3SBio will distribute its stake in-specie. There will be a concurrent global offering, the details of which are still to be fleshed out. 
  • Mandi (MANDI HK), a ” hair loss and weight management treatments” solutions provider, accounted for 17% of 3SBio’s revs in the 1H25, and 12.5% of profit.

UltraGreen.ai Pre-IPO: Strong Financials Despite Misleading Branding

By Hong Jie Seow

  • UltraGreen.AI (2594794D SP) is looking to raise US$400m in its upcoming Singapore IPO.
  • Ultragreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
  • In this note, we look at the company’s past performance.

Primer: Apellis Pharmaceuticals (APLS US) – Nov 2025

By αSK

  • Apellis is a commercial-stage biopharmaceutical company with a first-in-class C3 inhibitor platform, having successfully launched two products: SYFOVRE for Geographic Atrophy (GA) and EMPAVELI for Paroxysmal Nocturnal Hemoglobinuria (PNH).
  • The company is experiencing a significant revenue ramp, driven by the strong uptake of SYFOVRE, the first-ever approved treatment for GA, addressing a large and underserved market. This has shifted the company’s financial profile towards profitability.
  • Key risks center on the commercial execution and long-term safety profile of SYFOVRE, particularly concerning rare instances of retinal vasculitis, and intense competition in both the GA and PNH markets from established and emerging players.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Bristol Myers Crashes Again: Another Trial Failure Shocks Investors

By Baptista Research

  • Bristol Myers Squibb has once again found itself in the spotlight for all the wrong reasons, with the company announcing that it has halted a Phase 3 trial of its experimental blood thinner, milvexian.
  • The trial, which targeted patients recovering from acute coronary syndrome, was deemed unlikely to meet its primary endpoint by an independent data monitoring committee.
  • The news, which broke on November 14, 2025, led to a 3.1% drop in BMY shares, contributing to a year-to-date decline of 17%.

(20 Nov 2025) Chordia Therapeutics<190A> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Chordia Therapeutics, a biotech firm from Takeda, is developing the CLK inhibitor rogocekib (CTX-712) for blood cancer treatment.
  • The company aims to apply for regulatory approval for rogocekib by late 2028, following promising Phase 1 trial results in Japan.
  • Chordia went public in June 2024 and plans to handle manufacturing and sales in Japan while exploring international licensing opportunities.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


(20 Nov 2025) Chordia Therapeutics(190A JP) — Fisco Company Research

By FISCO

Key points (machine generated)

  • Chordia Therapeutics, a biotech company from Takeda, is developing anticancer drugs, focusing on rogocekib, a CLK inhibitor.
  • The company plans to apply for approval of rogocekib in the second half of 2028 after successful Phase 1 trials in Japan.
  • Chordia went public in June 2024 and manages operations from research to clinical studies, with plans for in-house manufacturing and international licensing.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Cooper Companies at a Crossroads: Activists Want In, Will the Board Give In?

By Baptista Research

  • Cooper Companies surged over 6.5% in premarket trading following a bombshell report that activist investor Jana Partners has taken a stake in the company and is pushing for sweeping strategic changes, including a high-profile merger of its contact lens unit with rival Bausch + Lomb.
  • The news, first reported by the Wall Street Journal, has sent shockwaves through the vision care industry.
  • Jana, known for catalyzing structural change across multiple sectors, is also urging Cooper to improve its capital allocation and returns, hinting at broader dissatisfaction with management’s operational strategy.

Genmab’s $8 Billion Bet: What The Merus Deal Could Unlock!

By Baptista Research

  • Genmab A/S is making headlines again, this time by sealing the U.S. leveraged finance market’s biggest M&A funding since April with a $4.5 billion raise through junk bonds and a leveraged loan.
  • The Danish biotech giant is gearing up to acquire Merus N.V., a smaller Dutch peer, in a proposed $8 billion transaction announced on September 29, 2025.
  • This bold move comes amid Genmab’s rapidly scaling commercial operations and late-stage pipeline expansion, headlined by drugs like EPKINLY and Rina-S.

Halozyme’s Breakthrough Moment: Could Its Game-Changing Subcutaneous Tech Disrupt Cancer Care Forever?

By Baptista Research

  • Halozyme Therapeutics’ third quarter 2025 results show a strong financial performance driven by its ENHANZE drug delivery technology and significant growth in royalty revenue.
  • The company reported an impressive 52% increase year-over-year in royalty revenue, reaching $236 million.
  • This growth, along with total revenue of $354 million, reflects a 22% increase year-over-year.

Jazz Pharmaceuticals’ Ziihera Trial Rocks the Market—A New Era in Oncology?

By Baptista Research

  • In a week dominated by biotech headlines, few announcements carried more weight than the positive Phase 3 data for Ziihera, the HER2-targeted bispecific antibody developed by Jazz Pharmaceuticals and Zymeworks.
  • On November 18, 2025, Jazz Pharmaceuticals reported that the HERIZON-GEA-01 trial of Ziihera (zanidatamab) in first-line treatment of HER2-positive gastroesophageal adenocarcinoma (GEA) had met its endpoints, driving strong progression-free survival and overall survival results.
  • This milestone marks a significant leap in treatment options for one of the world’s most aggressive and deadly cancers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: LG Corp, Caster , Equifax Inc, Kelington Group, Uber Technologies and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle
  • (20 Nov 2025) Caster <9331> — Fisco Company Research
  • Equifax’s Vault Verify Acquisition: Can It Supercharge TWN & Government Growth?
  • Primer: Kelington Group (KGRB MK) – Nov 2025
  • Uber Technologies Pushes a Powerful Growth Flywheel Driven by AI


Korea’s 25% Dividend Tax Basically Locked In, Market Now Trading the 30% Payout Angle

By Sanghyun Park

  • Starting next week, the tax subcommittee is set to hash out the 25% proposal, and with the opposition unlikely to block it, the 25% top rate is basically locked in.
  • The street’s treating 30% payout as base case, betting on more upside. The committee may pick it up next week, with headlines likely hitting the KRX tape fast.
  • Locals are already chasing 30%+ payout, deep-value names, with gov’t aiming for a Taiwan-style re-rating. If dividend-tax headlines drop next week, these screened names could rip.

(20 Nov 2025) Caster <9331> — Fisco Company Research

By FISCO

Key points (machine generated)

  • Caster, listed on the Tokyo Stock Exchange Growth Market in October 2023, reported increased revenue but an operating loss for the fiscal year ending August 2025.
  • The company focuses on alleviating labor shortages for SMEs by connecting them with remote workers, promoting remote work normalization.
  • Caster has over 5,800 users, primarily from startups and SMEs, employs around 800 individuals, and operates entirely remotely.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only.


Equifax’s Vault Verify Acquisition: Can It Supercharge TWN & Government Growth?

By Baptista Research

  • Equifax Inc.’s results for the third quarter of 2025 reflect a period of robust revenue growth intertwined with complex operational adjustments.
  • The company reported a revenue of $1.54 billion, marking a growth of over 7% in both constant currency and reported dollars.
  • This performance surpassed the guidance provided in July by $25 million, primarily courtesy of strong performance in U.S. mortgage, Employment & Income Verification (EWS), and U.S. Information Solutions (USIS) non-mortgage sectors.

Primer: Kelington Group (KGRB MK) – Nov 2025

By αSK

  • Integrated Engineering and Industrial Gas Provider with Strong Regional Presence: Kelington Group Berhad (KGB) is a Malaysia-based investment holding company that provides integrated engineering services, construction, and general trading. The company operates through two main segments: Engineering and Industrial Gases, serving a diverse range of industries including electronics, semiconductor, petrochemical, and food and beverage across Malaysia, Singapore, China, and Taiwan.
  • Leveraging Growth in the Semiconductor Industry: A significant portion of KGB’s business is tied to the semiconductor sector through its Ultra-High Purity (UHP) division, which provides gas and chemical delivery solutions. The company is well-positioned to benefit from the long-term growth of the semiconductor industry, driven by advancements in AI, IoT, and electric vehicles. Recent expansion into Germany and Hong Kong is a strategic move to capture a larger share of the global semiconductor capital expenditure.
  • Diversified Business Model Mitigates Cyclicality: While the UHP segment is a primary revenue contributor, KGB has diversified its operations to include Process Engineering, General Contracting, and an Industrial Gases division. This diversification helps to mitigate the risks associated with the cyclical nature of the semiconductor industry and provides multiple avenues for growth. The industrial gases business, particularly the supply of liquid carbon dioxide (LCO2), is a key pillar for future growth with strong demand from the food and beverage sector.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Uber Technologies Pushes a Powerful Growth Flywheel Driven by AI

By Baptista Research

  • Uber Technologies, Inc. recently reported its third-quarter 2025 earnings, highlighting solid growth in its operations, both in Mobility and Delivery sectors.
  • The company recorded a marked increase in trips by 22%, the fastest growth since 2023, driven predominantly by enhancements in innovation and execution strategies.
  • As a result of strong audience engagement and operational efficiency, gross bookings grew by 21% while maintaining relatively stable pricing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Shawbrook, ICICI Bank Ltd, Keybridge Capital, Moon River Capital , Tejon Ranch , Toast , TPG Inc and more

By | Daily Briefs, Financials

In today’s briefing:

  • Quiddity Leaderboard F100/F250 Dec25: New ADDs Identified; Several M&A-Related Changes Likely
  • Long ICICI Bank (ICICIBC IN) Vs. Short Axis Bank (AXSB IN): Quant-Driven Pair Trade in Indian Banks
  • Primer: Keybridge Capital (KBC AU) – Nov 2025
  • MOO: Highly Economic PEA on the Endako Project
  • TRC: Investor Event Takeaways Costly ’25 Proxy Fight Likely Informs Company Willingness to Engage With Shareholders
  • Toast Inc: Doubling ARR With Tight Budget Control—Is This the Most Efficient Growth Story in Tech Right Now?
  • TPG Inc.: Riding The Global M&A Momentum to Strengthen Liquidity


Quiddity Leaderboard F100/F250 Dec25: New ADDs Identified; Several M&A-Related Changes Likely

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for F100 and F250 in the run-up to the December 2025 index rebal event.
  • Our latest estimates suggest there could be one regular change for F100 and four regular changes for the F250 index during the December 2025 rebal.
  • The index changes for the December 2025 rebal will be based on the close of 2nd December 2025 and announced after the close of 3rd December 2025.

Long ICICI Bank (ICICIBC IN) Vs. Short Axis Bank (AXSB IN): Quant-Driven Pair Trade in Indian Banks

By Gaudenz Schneider

  • Context: The Axis Bank (AXSB IN) vs. ICICI Bank (ICICIBC IN) price ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long ICICI Bank (ICICIBC IN) and short Axis Bank (AXSB IN) targets a 5% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Primer: Keybridge Capital (KBC AU) – Nov 2025

By αSK

  • Keybridge Capital is a small, opportunistic investment company with a highly volatile financial track record, characterized by significant swings in revenue and profitability.
  • The company’s strategy involves a diversified portfolio of equity and debt investments, with a recent history of engaging in specialized situations like stablecoin arbitrage and activist investing, exemplified by a profitable exit from Magellan Global Fund Options.
  • Extreme financial volatility, negative cash flows, a no-dividend policy to date, and a highly concentrated management structure present significant risks for investors, despite a recent profitable year and very low valuation multiples.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


MOO: Highly Economic PEA on the Endako Project

By Atrium Research

  • Moon River published a PEA on the potential restart of the 25% owned Endako Molybdenum Mine.
  • Endako is a large brownfield project that was once one of the largest molybdenum producers in North America.
  • The PEA depicted a highly profitable operation utilizing the substantial existing infrastructure; After-tax NPV8% was $790M & IRR was 40%.

TRC: Investor Event Takeaways Costly ’25 Proxy Fight Likely Informs Company Willingness to Engage With Shareholders

By Zacks Small Cap Research

  • TRC’s chief growth strategy revolves around 3 planned MPCs using non-dilutive JV funding.
  • Given that construction would be 2-3 years away, we believe the timeline does not meet shareholder objectives.
  • Investors are looking for earlier catalysts.

Toast Inc: Doubling ARR With Tight Budget Control—Is This the Most Efficient Growth Story in Tech Right Now?

By Baptista Research

  • Toast, a leading provider of point-of-sale and management platforms for restaurants, reported strong performance in its third-quarter results for 2025.
  • The company achieved notable milestones with annual recurring revenue (ARR) surpassing $2 billion, demonstrating robust 34% top-line growth, and maintaining a consistent adjusted EBITDA margin at 35%.
  • These achievements underscore Toast’s strengthened market presence and operational efficiency.

TPG Inc.: Riding The Global M&A Momentum to Strengthen Liquidity

By Baptista Research

  • TPG, a global asset management firm, highlighted several key trends and outcomes for the third quarter of 2025, which can be used to construct an investment thesis.
  • TPG reported a GAAP net income of $67 million and after-tax distributable earnings of $214 million, translating to $0.53 per share of Class A common stock.
  • The company declared a dividend of $0.45 per share, consistent with its history of shareholder remuneration.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars